Daiichi Sankyo US is the American subsidiary of Daiichi Sankyo Company, Limited, a global pharmaceutical company based in Tokyo, Japan. Established in 2006, the company operates from its U.S. headquarters in Basking Ridge, New Jersey. It focuses on developing innovative therapies, particularly in oncology and cardiovascular diseases, addressing significant healthcare challenges.

The company is involved in the development and commercialization of prescription medicines, with a strong emphasis on research and development of novel therapies. Daiichi Sankyo US aims to advance global clinical development and create new standards of care through its innovative medicines and drug delivery methods. With approximately 1,800 employees in the U.S. and a commitment to fostering a culture of innovation and collaboration, Daiichi Sankyo US is dedicated to improving patient outcomes and addressing unmet medical needs in healthcare.